Radiographic Axial Spondyloarthritis
📧 Sign up to get email alerts when something new happens for Radiographic Axial Spondyloarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) [Phase 2]
This clinical trial update reports that Merck's Tulisokibart (MK-7240) is currently recruiting for a Phase 2 study in radiographic axial spo…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Respiratory Function and S-index in Radiographic Axial Spondyloarthritis
This clinical trial update notes a completed study evaluating respiratory function and S-index in Radiographic axial spondyloarthritis. The …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Biomarkers in Ankylosing Spondylitis
A clinical trial update indicates a biomarker study for ankylosing spondylitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis [Phase 3]
Phase 3 clinical trial of ixekizumab in Chinese participants with radiographic axial spondyloarthritis has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis [Phase 3]
Phase 3 trial evaluating ixekizumab in TNF inhibitor–experienced participants with radiographic axial spondyloarthritis has completed, with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.